Actively Recruiting
Citicoline as Neuroprotector in Neonates Exposed to Hypoxia
Led by Sherief Abd-Elsalam · Updated on 2019-05-29
40
Participants Needed
1
Research Sites
565 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial
CONDITIONS
Official Title
Citicoline as Neuroprotector in Neonates Exposed to Hypoxia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Neonates with hypoxia
You will not qualify if you...
- Hypoxic ischemic encephalopathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sherief Abd-Elsalam
Cairo, Egypt
Actively Recruiting
Research Team
S
sherief abd-elsalam, ass. prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here